9th January 2022

Cardiff Health Tech Firm, Glucose Republic has now closed a £500,000 investment round from Deepbridge Capital and the Development Bank of Wales, to build a system focused on what impact food has by combining biology and software. The start-up was formed by Julian Shapley and David Haines, who were previously involved in developing the world's first mobile-connected diabetes management platform. 

The Glucose Republic system allows users to directly measure how their body is reacting to the foods they eat and the things they do. Every person has a unique food fingerprint, which shows how we react to foods - so understanding the impact glucose will enable customers to adapt their food plans to their own lifestyles. 

David Haines, Co-Founder & CEO of Glucose Republic commented: 

"We are delighted that Deepbridge and the Development Bank of Wales have joined our mission to help customers understand the impact of their food choices, and benefit from our glucose proposition.” 

Ben Carter, Investment Manager - Life Sciences at Deepbridge Capital said: 

“At Deepbridge, we invest in strong teams that have the skills and knowledge to create globally scalable products. We look forward to working in partnership with GR during its continued development and commercialisation.” 

Click here to find out more. (By following this link you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites).  

Other News